Emerging Topics in Heart Failure: Sodium-Glucose Co-Transporter 2 Inhibitors (SGLT2i) in HF

Arq Bras Cardiol. 2021 Feb;116(2):355-358. doi: 10.36660/abc.20210031.
[Article in English, Portuguese]
No abstract available

Publication types

  • Letter

MeSH terms

  • Diabetes Mellitus, Type 2* / drug therapy
  • Glucose
  • Heart Failure* / drug therapy
  • Humans
  • Sodium
  • Sodium-Glucose Transporter 2 Inhibitors* / adverse effects
  • Symporters*

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Symporters
  • Sodium
  • Glucose